Washington, D.C. (July 14, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement about the House Tri-Committee health care reform bill:
“PhRMA cannot support the Tri-Committee bill but we believe that patient-centered health care reform is still on the right track to becoming law. We support reforms that provide all Americans with access to high-quality, affordable health coverage, and also address the burden of disease, health care costs, and quality gaps, so that the U.S. health care system can reach its full potential in helping all Americans achieve the best possible health.
“In addition, we support public policies aimed at encouraging biomedical research and innovation to improve the lives of patients and foster a successful life sciences sector, which directly employs millions of American workers. Unfortunately, the House Tri-Committee bill fails to meet these criteria. Of particular concern are changes to the Medicare Part D benefit, which constitute a tax increase on seniors because of the resulting increase in their monthly premiums as projected by the Congressional Budget Office under similar proposals.
“Regardless, we will continue to work with the White House, Senate, and House leadership to ensure health care reform that is ultimately acceptable to seniors, patients and working families can be achieved this year."
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: http://www.phrma.org
For information on how innovative medicines save lives, visit: http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org
For more information on public health emergencies, visit http://www.rxresponse.org
For information on the danger of imported drugs, visit: http://www.buysafedrugs.info